IRCT20120216009045N4招募中1 期
Evaluation of the Efficacy of nebulized 5% hypertonic saline on inflammatory factors and recovery of severe pneumonia in patients with Covid-19 hospitalized in intensive care units
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- All
入选标准
- •Patient with Covid-19 coronavirus (confirmation of diagnosis by positive PCR test)
- •Severe pneumonia due to COVID-19
- •Age 70 - 18 years
- •Conscious consent of the patient or her guardian in cases that the patient is not conscious.
排除标准
- •Receiving interleukin production inhibitors such as Octemra
- •Patients with a history of HIV + or any history of immunodeficiency
- •Patient with active bacterial pneumonia
- •Primary or metastatic lung cancer
- •History of any cancer or malignancy
- •Chronic lung diseases include: pulmonary fibrosis, bronchiectasis, asthma
- •Previous thoracic and lung surgery
- •Patients with hypernatremia
- •Intubated patients
研究者
相似试验
已完成
3 期
Eeffect of Nebulized hypertonic saline solution on treatment of infant with viral bronchiolitisAcute bronchiolitisIRCT138903134096N1Vice Chancellor of Research, Bushehr University of Medical Sciences60
已完成
Unknown
Comparison of 0.5% spinal levobupivacaine vs 0.5% bupivacaineCTRI/2023/07/055644BHABHA ATOMIC RESEARCH CENTRE HOSPITAL, MUMBAI40
招募中
早期 1 期
Inhalation of stem cell products in patients with covid-19IRCT20210919052520N1Kerman University of Medical Sciences15
尚未招募
2 期
How Effective is Nebulization With 3% Hypertonic Saline Against 0.9% Normal Saline In Children With Viral Lung Infection.CTRI/2024/02/063234E AJAYA KUMAR
已完成
3 期
Comparing Therapeutic effects of combination of high volume normal saline and salbutamol nebulizer with combination of hypertonic saline 3% and salbutamol nebulizer in bronchiolitis treatmentBronchiolitis.Other acute lower respiratory infectionsJ20, J21,JIRCT2016022826809N1Vice chancellor for research,Zahedan University of Medical Sciences180